The trademark application THYROVANZ was filed by Provanz Supplements Inc, a U.S. corporation (the "Applicant"). The application was published for oppositions on September 14, 2022, and it was registered by office on December 22, 2022 without any oppositions.
The application was filed in English (Spanish was selected as the second language).